Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martin Voss

Showing results (61-70 of 108) with videos related to

Pageof 11
Sort By:
BJU International|September 19, 2006
The role of the lymphatic system and its specific growth factor, vascular endothelial growth factor C, for lymphogenic metastasis in prostate cancerLutz Trojan, Florian Rensch, Martin Voss, et al.
Journal of Neurology|February 1, 2018
New MR perfusion features in primary central nervous system lymphomas: pattern and prognostic impactStella Blasel, Rieke Vorwerk, Makoto Kiyose, et al.
Neurosurgical Focus|January 1, 2021
Neurotoxicity of subarachnoid Gd-based contrast agent accumulation: a potential complication of intraoperative MRI?Monika Lauer, Arne Lauer, Se-Jong You, et al.
Journal of Neuro-Oncology|January 4, 2019
Contrast enhancing spots as a new pattern of late onset pseudoprogression in glioma patientsMartin Voss, Kea Franz, Joachim P Steinbach, et al.
Cellular Signalling|August 31, 2010
Ppm1E is an in cellulo AMP-activated protein kinase phosphataseMartin Voss, James Paterson, Ian R Kelsall, et al.
Frontiers in Oncology|August 16, 2021
Dexamethasone Treatment Limits Efficacy of Radiation, but Does Not Interfere With Glioma Cell Death Induced by Tumor Treating FieldsBenedikt Linder, Abigail Schiesl, Martin Voss, et al.
Viruses|April 23, 2022
A Conserved Cysteine Residue in Coxsackievirus B3 Protein 3A with Implication for Elevated VirulenceMartin Voss, Sandra Pinkert, Meike Kespohl, et al.
Epilepsy & Behavior : E&B|April 21, 2017
Treatment of refractory and super-refractory status epilepticus with brivaracetam: A cohort study from two German university hospitalsAdam Strzelczyk, Isabel Steinig, Laurent M Willems, et al.
Journal of Cancer Research and Clinical Oncology|November 8, 2022
Outcome and characteristics of patients with adult grade 4 diffuse gliomas changing sites of treatmentMarie-Therese Forster, Marion Hug, Maximilian Geissler, et al.
Frontiers in Oncology|April 25, 2022
Neurocognitive Outcome and Seizure Freedom After Awake Surgery of GliomasSarah Christina Reitz, Marion Behrens, Irina Lortz, et al.
Pageof 11

Showing results (61-70 of 108) with videos related to

Sort By:
Pageof 11
BJU International|September 19, 2006
The role of the lymphatic system and its specific growth factor, vascular endothelial growth factor C, for lymphogenic metastasis in prostate cancerLutz Trojan, Florian Rensch, Martin Voss, et al.
Journal of Neurology|February 1, 2018
New MR perfusion features in primary central nervous system lymphomas: pattern and prognostic impactStella Blasel, Rieke Vorwerk, Makoto Kiyose, et al.
Neurosurgical Focus|January 1, 2021
Neurotoxicity of subarachnoid Gd-based contrast agent accumulation: a potential complication of intraoperative MRI?Monika Lauer, Arne Lauer, Se-Jong You, et al.
Journal of Neuro-Oncology|January 4, 2019
Contrast enhancing spots as a new pattern of late onset pseudoprogression in glioma patientsMartin Voss, Kea Franz, Joachim P Steinbach, et al.
Cellular Signalling|August 31, 2010
Ppm1E is an in cellulo AMP-activated protein kinase phosphataseMartin Voss, James Paterson, Ian R Kelsall, et al.
Frontiers in Oncology|August 16, 2021
Dexamethasone Treatment Limits Efficacy of Radiation, but Does Not Interfere With Glioma Cell Death Induced by Tumor Treating FieldsBenedikt Linder, Abigail Schiesl, Martin Voss, et al.
Viruses|April 23, 2022
A Conserved Cysteine Residue in Coxsackievirus B3 Protein 3A with Implication for Elevated VirulenceMartin Voss, Sandra Pinkert, Meike Kespohl, et al.
Epilepsy & Behavior : E&B|April 21, 2017
Treatment of refractory and super-refractory status epilepticus with brivaracetam: A cohort study from two German university hospitalsAdam Strzelczyk, Isabel Steinig, Laurent M Willems, et al.
Journal of Cancer Research and Clinical Oncology|November 8, 2022
Outcome and characteristics of patients with adult grade 4 diffuse gliomas changing sites of treatmentMarie-Therese Forster, Marion Hug, Maximilian Geissler, et al.
Frontiers in Oncology|April 25, 2022
Neurocognitive Outcome and Seizure Freedom After Awake Surgery of GliomasSarah Christina Reitz, Marion Behrens, Irina Lortz, et al.
Pageof 11